COGT   $10.92  3.51% Market Closed After Close 11.088039 1.54%

Cogent Biosciences Inc
Total Cash 363.22M
totalCashPerShare 3.319
EBITDA -242.22M
Total Debt 18.18M
quickRatio 9.08
currentRatio 9.249
Total Revenue
debtToEquity 4.872
Revenue/Share
ROA -0.37182
ROE -0.62924
grossProfits
freeCashflow -100.41M
operatingCashflow -177.27M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 932.55M
forwardPE -4.747826
floatShares 70.23M
sharesOutstanding 109.45M
sharesShort 10.25M
sharesShortPriorMonth 10.11M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.12%
Short Ratio help_outline 12.84%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 2.37
Price To Book help_outline 4.61
earningsQuarterlyGrowth
netIncomeToCommon -227.04M
trailingEps -2.49%
forwardEps -2.30%
enterpriseToEbitda -3.85
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.57 3Q 2024
institutionsCount 209
lastUpdated Sept. 16, 2024, 8:03 p.m.